Company

Merck & Co Inc MRK

Tracked across 13 disclosed holders on Protégé.

8 tracked investors, latest 13F quarter ending 30 Jun 2026 · 4 members of Congress · 1 executive · latest filing 7 Oct 2026

Held by these investors

All of 8 tracked investors by weight in their own portfolio. Source: each investor's latest SEC Form 13F-HR; quarter end and filing date per row.
InvestorWeight in portfolioValue (13F)Quarter endingFiled
Antipodes Partners2.6%$141.0M2026-06-302026-08-06
Samlyn Capital1.2%$72.7M2026-06-302026-08-14
Alyeska Investment Group0.8%$318.8M2026-06-302026-08-14
Voleon Group0.7%$38.0M2026-06-302026-08-14
Woodline Partners0.4%$144.5M2026-06-302026-08-14
Adage Capital Management0.4%$260.9M2026-06-302026-08-14
Cliff Asness0.4%$1.0B2026-06-302026-08-14
Farallon Capital Management0.2%$25.6M2026-06-302026-08-14

Members of Congress who disclosed trades

Disclosed trades by members of Congress. Net is buys minus sells at range midpoints. Source: STOCK Act periodic transaction reports; latest trade date per row.
PoliticianDisclosed activityEst. netLatest trade
Maria Elvira Salazar2 buys / 1 sell$57K2026-09-24
Josh Gottheimer1 buy / 0 sells$8K2026-02-04
Jared Moskowitz1 buy / 0 sells$8K2024-11-08
Julie Johnson0 buys / 1 sell-$8K2025-12-18

Company executives who disclosed trades

Executives' own trades in this company's stock. Source: SEC Form 4; latest trade date per row.
ExecutiveDisclosed activityNetLatest trade
Robert Davis0 buys / 1 sell-$5.6M2026-02-04

Sources: SEC EDGAR (Form 13F-HR and Form 4) and the official House and Senate STOCK Act disclosures. Filings are quarterly or delayed, so current holdings may differ. Weights are each holder's own portfolio share, not a share of the company.

Open the companies explorer for MRK